TABLE 1.
All (N = 481) |
Wave 2 Participants |
Wave 2 Dropouts |
|
---|---|---|---|
M (SD)/n (%) | M (SD)/n (%) | M (SD)/n (%) | |
| |||
Demographics | |||
Sex | |||
Men | 281 (58.4%) | 241 (56.8%) | 40 (70.2%) |
Women | 200 (72.7%) | 183 (43.2%) | 17 (29.8%) |
Age | 62.18 (12.04) | 62.28 (12.86) | 62.33 (12.73) |
Race | |||
Non-White | 47 (9.8%) | 241 (9.7%) | 40 (10.5%) |
White | 434 (90.2%) | 283 (90.3%) | 51 (89.5%) |
Marital status | |||
Living alone | 131 (27.3%) | 119 (28.1%) | 12 (21.1%) |
With spouse or others | 349 (72.7%) | 304 (71.9%) | 45 (78.9%) |
Education, yrs | 14.03 (3.30) | 14.02 (3.22) | 14.06 (3.91) |
Family income, $ | 56,728 (56,197) | 56,571 (51,754) | 58,650 (58,669) |
Psychological risk | |||
Pre-OHS anxiety | 35.77 (10.06) | 36.06 (12.61) | 38.67 (12.37)* |
Overall health factors | |||
Medical comorbidities | 2.97 (2.33) | 2.97 (2.30) | 2.96 (2.57) |
BMI | 27.26 (5.40) | 27.31 (5.48) | 26.94 (4.75) |
STS medical indices | |||
Cardiac risk factors (1 = yes, 2 = no) | |||
Smoker | 262 (54.8%) | 220 (52.0%) | 42 (76.4%)** |
Diabetes | 92 (19.2%) | 81 (19.1%) | 11 (20.0%) |
Hypercholesterolemia | 186 (38.9%) | 164 (38.8%) | 22 (40.0%) |
Hypertension | 281 (58.8%) | 250 (59.1%) | 31 (56.4%) |
Renal failure | 32 (6.7%) | 26 (6.1%) | 6 (10.9%) |
Chronic lung disease | |||
No | 429 (89.7%) | 380 (89.8%) | 49 (89.1%) |
Mild | 33 (6.9%) | 30 (7.1%) | 3 (5.5%) |
Moderate | 9 (1.9%) | 7 (1.7%) | 2 (3.6%) |
Severe | 7 (1.5%) | 6 (1.4%) | 1 (1.8%) |
HD-specific indices (1 = yes, 2 = no) (except the last two items) | |||
Angina | 171 (35.8%) | 147 (34.8%) | 24 (29.0%) |
Arrhythmia | 80 (16.7%) | 73 (17.3%) | 7 (43.6%) |
Left main disease >50% | 26 (5.7%) | 21 (5.2%) | 5 (9.1%) |
MI | 114 (23.8%) | 99 (3.4%) | 15 (27.3%) |
CHF | 221 (46.2%) | 198 (46.7%) | 23 (41.8%) |
CABG | 169 (35.4%) | 144 (34.0%) | 25 (44.5%) |
No. diseased coronary vessels | |||
None | 252 (54.3%) | 223 (54.5%) | 29 (52.7%) |
One | 57 (12.3%) | 50 (12.2%) | 7 (12.7%) |
Two | 42 (9.1%) | 39 (9.5%) | 3 (5.5%) |
Three | 113 (24.4%) | 97 (23.7%) | 16 (29.1%) |
NYHA classification | |||
I | 179 (37.6%) | 156 (37.0%) | 23 (42.6%) |
II | 167 (35.1%) | 145 (34.4%) | 22 (40.7%) |
III | 115 (24.2%) | 107 (25.4%) | 8 (14.8%) |
IV | 15 (3.2%) | 14 (3.2%) | 1 (1.9%) |
p < 0.05.
p < 0.01.